U.S. flag

An official website of the United States government

GRCh37/hg19 10q11.22-11.23(chr10:46269493-51874356)x1 AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 14, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002474544.1

Allele description [Variation Report for GRCh37/hg19 10q11.22-11.23(chr10:46269493-51874356)x1]

GRCh37/hg19 10q11.22-11.23(chr10:46269493-51874356)x1

Genes:
  • AGAP10:ArfGAP with GTPase domain, ankyrin repeat and PH domain 10 [Gene]
  • AGAP4:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4 [Gene - HGNC]
  • AGAP6:ArfGAP with GTPase domain, ankyrin repeat and PH domain 6 [Gene - HGNC]
  • AGAP9:ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 [Gene - HGNC]
  • ERCC6:ERCC excision repair 6, chromatin remodeling factor [Gene - OMIM - HGNC]
  • FRMPD2:FERM and PDZ domain containing 2 [Gene - OMIM - HGNC]
  • GPRIN2:G protein regulated inducer of neurite outgrowth 2 [Gene - OMIM - HGNC]
  • ARHGAP22:Rho GTPase activating protein 22 [Gene - OMIM - HGNC]
  • VSTM4:V-set and transmembrane domain containing 4 [Gene - HGNC]
  • WASHC2A:WASH complex subunit 2A [Gene - HGNC]
  • WASHC2C:WASH complex subunit 2C [Gene - OMIM - HGNC]
  • WDFY4:WDFY family member 4 [Gene - OMIM - HGNC]
  • ANXA8L1:annexin A8 like 1 [Gene - HGNC]
  • ANXA8:annexin A8 [Gene - OMIM - HGNC]
  • CHAT:choline O-acetyltransferase [Gene - OMIM - HGNC]
  • C10orf53:chromosome 10 open reading frame 53 [Gene - HGNC]
  • C10orf71:chromosome 10 open reading frame 71 [Gene - HGNC]
  • DRGX:dorsal root ganglia homeobox [Gene - OMIM - HGNC]
  • FAM170B:family with sequence similarity 170 member B [Gene - HGNC]
  • FAM25C:family with sequence similarity 25 member C [Gene - HGNC]
  • FAM25E:family with sequence similarity 25 member E [Gene - HGNC]
  • FAM25G:family with sequence similarity 25 member G [Gene - HGNC]
  • GDF10:growth differentiation factor 10 [Gene - OMIM - HGNC]
  • GDF2:growth differentiation factor 2 [Gene - OMIM - HGNC]
  • LRRC18:leucine rich repeat containing 18 [Gene - OMIM - HGNC]
  • MSMB:microseminoprotein beta [Gene - OMIM - HGNC]
  • MAPK8:mitogen-activated protein kinase 8 [Gene - OMIM - HGNC]
  • NPY4R:neuropeptide Y receptor Y4 [Gene - OMIM - HGNC]
  • NCOA4:nuclear receptor coactivator 4 [Gene - OMIM - HGNC]
  • OGDHL:oxoglutarate dehydrogenase L [Gene - OMIM - HGNC]
  • PGBD3:piggyBac transposable element derived 3 [Gene - HGNC]
  • PARG:poly(ADP-ribose) glycohydrolase [Gene - OMIM - HGNC]
  • PTPN20:protein tyrosine phosphatase non-receptor type 20 [Gene - OMIM - HGNC]
  • RBP3:retinol binding protein 3 [Gene - OMIM - HGNC]
  • SLC18A3:solute carrier family 18 member A3 [Gene - OMIM - HGNC]
  • SYT15:synaptotagmin 15 [Gene - OMIM - HGNC]
  • TIMM23:translocase of inner mitochondrial membrane 23 [Gene - OMIM - HGNC]
  • TMEM273:transmembrane protein 273 [Gene - HGNC]
  • ZNF488:zinc finger protein 488 [Gene - HGNC]
Variant type:
copy number loss
Cytogenetic location:
10q11.22-11.23
Genomic location:
Chr10: 46269493 - 51874356 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 10q11.22-11.23(chr10:46269493-51874356)x1
HGVS:

    Condition(s)

    Synonyms:
    none provided
    Identifiers:
    MedGen: CN517202

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV002771940Quest Diagnostics Nichols Institute San Juan Capistrano
    criteria provided, single submitter

    (ACMG/ClinGen CNV Guidelines, 2019)
    Likely pathogenic
    (Jun 14, 2022)
    unknownclinical testing

    PubMed (1)
    [See all records that cite this PMID]

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

    Citations

    PubMed

    Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).

    Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin CL.

    Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6. Erratum in: Genet Med. 2021 Nov;23(11):2230. doi: 10.1038/s41436-021-01150-9.

    PubMed [citation]
    PMID:
    31690835
    PMCID:
    PMC7313390

    Details of each submission

    From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV002771940.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testing PubMed (1)

    Description

    The copy number loss of 10q11.22q11.23 involves several protein-coding genes, including GDF2 (OMIM 605120). Deletions overlapping with the 10q11.2 recurrent region (LCR C-D) have been reported in individuals with developmental delay and intellectual disability, as well as variable other features, including hypotonia, sleep apnea, chronic constipation, gastroesophageal and vesicoureteral refluxes, behavioral anomalies, epilepsy, ataxia, dysphagia, nystagmus, and ptosis. The clinical variability and frequent inheritance of deletions from apparently healthy parents suggest variable phenotypic expressivity and incomplete penetrance influenced by additional genetic and/or nongenetic modifiers (Schwartz 2018, Stankiewicz 2012). The proposed 1.45 Mb smallest region of overlap of approximately 1.5 Mb between LCR-C and LCR-D is encompassed in the current deletion. Additionally, a live born fetus with no anomalies was reported who carried an overlapping 3.4-Mb inherited deletion of 10q11.22q11.23. However, it was unknown whether this individual will develop neurocognitive and/or behavioral abnormalities in the future and there was no follow-up report on that patient. The authors categorized the region as a susceptibility locus (Govaerts 2017). Further, heterozygous missense variants of GDF2 are associated with autosomal dominant hereditary hemorrhagic telangiectasia type 5 (OMIM 615506), and multiple recent studies have proposed an association between GDF2 loss of function variants and autosomal dominant pulmonary arterial hypertension (Zhu 2019, Wang 2019, Eyries 2019, Graf 2018). Thus, based on review of the current literature, this copy number variant (CNV) is interpreted as likely pathogenic. However, an abnormal phenotype is not fully predictable. References: Eyries et al., Eur Respir J. 2019 Mar 14;53(3):1801371. PMID: 30578383. Govaerts et al., Prenat Diagn. 2017 Jan;37(1):73-80. PMID: 27931090. Graf et al., Nat Commun. 2018 Apr 12;9(1):1416. PMID: 29650961. Schwartz et al., Am J Med Genet A. 2018 Jan;176(1):151-155. PMID: 29130637. Stankiewicz et al., Hum Mutat. 2012 Jan;33(1):165-79. PMID: 21948486. Wang et al., Eur Respir J. 2019 Mar 14;53(3):1801609. PMID: 30578397. Zhu et al., Genome Med. 2019 Nov 14;11(1):69. PMID: 31727138.

    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Mar 26, 2023